Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 08 08 2023
accepted: 22 09 2023
medline: 23 10 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: epublish

Résumé

Joint replacement surgery is the most effective treatment for end-stage arthritis. Aseptic loosening caused by periprosthetic osteolysis is a common complication after joint replacement. Inflammation induced by wear particles derived from prosthetic biomaterials is a major cause of osteolysis. We emphasize that bone marrow-derived macrophages and their fusion-derived osteoclasts play a key role in this pathological process. Researchers have developed multiple intervention approaches to regulate macrophage/osteoclast activation. Aiming at wear particle-induced periprosthetic aseptic osteolysis, this review separately discusses the molecular mechanism of regulation of ROS formation and inflammatory response through intervention of macrophage/osteoclast RANKL-MAPKs-NF-κB pathway. These molecular mechanisms regulate osteoclast activation in different ways, but they are not isolated from each other. There is also a lot of crosstalk among the different mechanisms. In addition, other bone and joint diseases related to osteoclast activation are also briefly introduced. Therefore, we discuss these new findings in the context of existing work with a view to developing new strategies for wear particle-associated osteolysis based on the regulation of macrophages/osteoclasts.

Identifiants

pubmed: 37860014
doi: 10.3389/fimmu.2023.1274679
pmc: PMC10582964
doi:

Substances chimiques

NF-kappa B 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1274679

Informations de copyright

Copyright © 2023 Yin, Gong, Liu and Yin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Rev Rheumatol. 2011 Sep 06;7(10):600-8
pubmed: 21894210
J Biomed Mater Res A. 2013 Oct;101(10):3033-45
pubmed: 23568608
Immunity. 2016 Mar 15;44(3):439-449
pubmed: 26982352
Front Pharmacol. 2016 Dec 22;7:503
pubmed: 28066250
Cell Prolif. 2020 Feb;53(2):e12743
pubmed: 31943455
Blood. 2009 Aug 20;114(8):1633-44
pubmed: 19546479
Science. 2000 Sep 1;289(5484):1508-14
pubmed: 10968781
Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383
pubmed: 32231263
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Front Pharmacol. 2020 Apr 03;11:385
pubmed: 32317967
NCHS Data Brief. 2021 Mar;(405):1-8
pubmed: 34029181
J Arthroplasty. 2020 Aug;35(8):2200-2203
pubmed: 32247671
Front Endocrinol (Lausanne). 2022 May 18;13:885507
pubmed: 35663327
Int Immunopharmacol. 2023 Apr;117:109991
pubmed: 37012875
J Biomed Mater Res A. 2017 Feb;105(2):510-520
pubmed: 27667508
Curr Med Chem. 2012;19(32):5524-35
pubmed: 22963665
Expert Rev Clin Immunol. 2018 Aug;14(8):695-706
pubmed: 30099915
Biomaterials. 2016 Feb;80:1-10
pubmed: 26695376
Front Pharmacol. 2021 Nov 03;12:746391
pubmed: 34803690
J Cell Physiol. 2022 Mar;237(3):1790-1803
pubmed: 34796915
Lancet Diabetes Endocrinol. 2017 Nov;5(11):898-907
pubmed: 28689769
Phytomedicine. 2018 Dec 1;51:181-190
pubmed: 30466615
Nat Commun. 2022 Jun 27;13(1):3684
pubmed: 35760800
Trends Mol Med. 2020 Feb;26(2):185-200
pubmed: 31679988
Exp Physiol. 1997 Mar;82(2):291-5
pubmed: 9129943
Nano Lett. 2019 May 8;19(5):3040-3048
pubmed: 30968694
Front Immunol. 2022 Jun 30;13:934084
pubmed: 35844489
Clin Exp Metastasis. 2011 Oct;28(7):649-59
pubmed: 21688034
Nat Med. 2015 Mar;21(3):281-7
pubmed: 25706873
J Natl Cancer Inst. 2005 Jan 5;97(1):59-69
pubmed: 15632381
Gene Ther. 2004 Feb;11(4):402-7
pubmed: 14724679
Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
pubmed: 9240432
Immunity. 2020 Jun 16;52(6):957-970
pubmed: 32553181
Acta Orthop. 2010 Dec;81(6):667-73
pubmed: 20919816
Front Cell Dev Biol. 2021 Mar 18;9:648866
pubmed: 33816498
Bioeng Transl Med. 2021 Jun 08;6(3):e10232
pubmed: 34589604
Bioact Mater. 2021 Jul 01;8:435-448
pubmed: 34541412
J Arthroplasty. 2018 May;33(5):1309-1314.e2
pubmed: 29551303
J Clin Invest. 2003 Mar;111(6):821-31
pubmed: 12639988
Free Radic Biol Med. 2013 Dec;65:789-799
pubmed: 23954472
J Orthop Trauma. 2020 Jan;34(1):8-17
pubmed: 31855973
J Rheumatol. 2019 Sep;46(9):1134-1140
pubmed: 30988126
N Engl J Med. 2007 Aug 16;357(7):654-63
pubmed: 17699815
ACS Appl Mater Interfaces. 2014 Jul 9;6(13):9955-65
pubmed: 24826838
J Nanobiotechnology. 2022 Dec 14;20(1):532
pubmed: 36517801
Int J Mol Sci. 2021 Jan 28;22(3):
pubmed: 33525753
J Biomed Mater Res A. 2017 Nov;105(11):3169-3175
pubmed: 28782280
Cytokine Growth Factor Rev. 2004 Dec;15(6):457-75
pubmed: 15561602
PLoS One. 2013 May 27;8(5):e63967
pubmed: 23724011
J Clin Invest. 2001 May;107(10):1235-44
pubmed: 11375413
Front Pharmacol. 2022 Jan 20;12:810322
pubmed: 35126144
Bone. 2014 Jun;63:36-46
pubmed: 24521946
J Long Term Eff Med Implants. 2016;26(4):303-309
pubmed: 29199615
Sci Transl Med. 2016 Aug 24;8(353):353ra113
pubmed: 27559096
J Biomed Mater Res A. 2020 Sep;108(9):1792-1805
pubmed: 32198815
Sci Transl Med. 2019 May 29;11(494):
pubmed: 31142679
Am J Pathol. 2004 Nov;165(5):1819-26
pubmed: 15509550
Acta Biomater. 2020 Jan 15;102:416-426
pubmed: 31760223
Arthritis Rheum. 2010 Feb;62(2):402-13
pubmed: 20112358
J Clin Med. 2019 Dec 01;8(12):
pubmed: 31805704
Am J Transl Res. 2019 Mar 15;11(3):1154-1169
pubmed: 30972153
Front Immunol. 2023 May 19;14:1186393
pubmed: 37275919
Acta Biomater. 2019 Apr 15;89:242-251
pubmed: 30880234
Leukemia. 2017 Dec;31(12):2686-2694
pubmed: 28529307
Cell Res. 2012 Sep;22(9):1356-73
pubmed: 22688893
Sci Adv. 2016 Jul 29;2(7):e1600584
pubmed: 27482540
Nature. 1990 May 31;345(6274):442-4
pubmed: 2188141
Cell. 1996 Oct 4;87(1):13-20
pubmed: 8858144
Science. 2001 Aug 24;293(5534):1495-9
pubmed: 11520989
Mar Drugs. 2021 Feb 27;19(3):
pubmed: 33673704
Cell Biochem Funct. 2006 May-Jun;24(3):275-81
pubmed: 15898125
Int J Mol Sci. 2022 Mar 05;23(5):
pubmed: 35270008
Cell Prolif. 2020 Oct;53(10):e12882
pubmed: 32871020
J Biomed Mater Res B Appl Biomater. 2013 Apr;101(3):458-66
pubmed: 23436622
Cell. 1998 Apr 17;93(2):165-76
pubmed: 9568710
Mol Med. 2022 Nov 26;28(1):141
pubmed: 36435772
J Cell Sci. 2020 Jul 1;133(13):
pubmed: 32611680
Bone Res. 2021 Jan 11;9(1):4
pubmed: 33424022
Front Oncol. 2014 Dec 15;4:364
pubmed: 25566502
Curr Osteoporos Rep. 2022 Feb;20(1):43-52
pubmed: 35133558
Clin Microbiol Infect. 2020 May;26(5):572-578
pubmed: 31446152
Exp Ther Med. 2021 Jul;22(1):712
pubmed: 34007321
J Immunol. 2008 Mar 15;180(6):4308-15
pubmed: 18322244
Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):585-597
pubmed: 27825853
Bone Res. 2022 Aug 26;10(1):56
pubmed: 36028492
FEMS Immunol Med Microbiol. 2007 Apr;49(3):425-32
pubmed: 17343684
Toxicology. 2000 Nov 16;153(1-3):83-104
pubmed: 11090949
Arch Orthop Trauma Surg. 2001 Jul;121(7):399-402
pubmed: 11510905
ACS Nano. 2023 Jan 10;17(1):322-336
pubmed: 36525314
Bioact Mater. 2023 Mar 03;26:181-193
pubmed: 36911207
Int J Mol Sci. 2018 Feb 17;19(2):
pubmed: 29463002
Biomater Sci. 2021 Jul 13;9(14):4922-4935
pubmed: 34052845
Nat Rev Immunol. 2021 Jun;21(6):363-381
pubmed: 33340021
Acta Biomater. 2018 Jan;65:417-425
pubmed: 29109029
Cancer Treat Rev. 2010 Dec;36(8):615-20
pubmed: 20478658
Nat Rev Dis Primers. 2016 Sep 29;2:16069
pubmed: 27681935
Bonekey Rep. 2013 Jun 05;2:361
pubmed: 24578825
Front Pharmacol. 2020 Feb 10;10:1696
pubmed: 32116686
Acta Biomater. 2023 Apr 1;160:297-310
pubmed: 36773884
Cell Cycle. 2018;17(17):2134-2145
pubmed: 30176162
J Virol. 2014 Sep 1;88(17):9830-41
pubmed: 24942571
Front Immunol. 2015 Jul 01;6:328
pubmed: 26191061
Biomaterials. 2022 Sep;288:121742
pubmed: 36030105
Eur J Pharmacol. 2022 Jun 5;924:174941
pubmed: 35398031
Int J Mol Sci. 2023 Feb 09;24(4):
pubmed: 36834920
J Invest Dermatol. 2009 Jun;129(6):1327-38
pubmed: 19262604
J Biol Chem. 2008 Aug 29;283(35):23863-71
pubmed: 18579519
Infect Immun. 2014 Nov;82(11):4508-17
pubmed: 25114117
Front Immunol. 2019 Jul 26;10:1760
pubmed: 31402917
Expert Opin Biol Ther. 2016;16(4):489-506
pubmed: 26817494
Nat Commun. 2016 May 23;7:11624
pubmed: 27211851
Front Immunol. 2019 Feb 05;10:97
pubmed: 30804932
Front Endocrinol (Lausanne). 2022 Nov 08;13:939959
pubmed: 36425467
Expert Rev Med Devices. 2020 Jan;17(1):41-56
pubmed: 31810395
J Bone Miner Metab. 2007;25(5):277-85
pubmed: 17704992
Int J Nanomedicine. 2019 Aug 01;14:6019-6033
pubmed: 31534334
Nat Commun. 2016 Oct 19;7:13176
pubmed: 27759007
Acta Biochim Biophys Sin (Shanghai). 2022 Aug 25;54(8):1068-1079
pubmed: 35929596
J Orthop Res. 2012 Mar;30(3):341-7
pubmed: 21866572
J Natl Cancer Inst. 2019 Dec 1;111(12):1298-1306
pubmed: 31093668
ACS Appl Mater Interfaces. 2014 Jun 11;6(11):8580-9
pubmed: 24720634
Nano Lett. 2019 Jan 9;19(1):124-134
pubmed: 30521345
Drug Des Devel Ther. 2021 Nov 23;15:4741-4757
pubmed: 34848946
Mol Endocrinol. 2008 Jan;22(1):176-85
pubmed: 17885208
Clin Orthop Relat Res. 2006 Oct;451:229-35
pubmed: 16735873
Cell Biosci. 2023 Mar 13;13(1):55
pubmed: 36915206
ACS Appl Mater Interfaces. 2023 Feb 1;15(4):4935-4946
pubmed: 36657969
J Clin Invest. 2022 Sep 15;132(18):
pubmed: 35881476
J Cell Biochem. 2004 Mar 1;91(4):718-29
pubmed: 14991763
Acta Orthop Belg. 2013 Feb;79(1):1-9
pubmed: 23547507
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4828-32
pubmed: 2191302
Int J Biol Sci. 2016 Nov 25;12(12):1472-1487
pubmed: 27994512
Front Immunol. 2022 Aug 08;13:936995
pubmed: 36003376
Front Pharmacol. 2018 May 11;9:474
pubmed: 29867480
Blood. 2005 Aug 1;106(3):852-9
pubmed: 15817678
Biosci Rep. 2019 Sep 9;39(9):
pubmed: 31413169
J Nanobiotechnology. 2023 Mar 20;21(1):98
pubmed: 36941678
J Am Acad Orthop Surg. 2018 Jan 15;26(2):45-57
pubmed: 29303922
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Cancer Lett. 2022 Feb 1;526:76-90
pubmed: 34801597
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2467-75
pubmed: 26883700
Biomaterials. 2005 Jun;26(16):2933-45
pubmed: 15603788
Front Immunol. 2022 Jul 04;13:892970
pubmed: 35860269
Front Cell Neurosci. 2022 Nov 17;16:949939
pubmed: 36467606
J Biol Chem. 2017 Mar 17;292(11):4686-4699
pubmed: 28130449
Nat Commun. 2016 Mar 07;7:10872
pubmed: 26947250
Cochrane Database Syst Rev. 2017 Oct 30;10:CD003474
pubmed: 29082518
Bone Res. 2023 Feb 24;11(1):10
pubmed: 36828839
Ann Rheum Dis. 2010 May;69(5):872-5
pubmed: 19734132
Inflamm Regen. 2018 Jun 23;38:16
pubmed: 29977413
Cell Death Dis. 2017 Jun 15;8(6):e2878
pubmed: 28617442
J Leukoc Biol. 1996 Feb;59(2):133-8
pubmed: 8603984
J Immunol. 2009 Aug 15;183(4):2397-406
pubmed: 19620301
J Control Release. 2023 Jan;353:535-548
pubmed: 36481693
Biomaterials. 2015 Aug;60:92-9
pubmed: 25985156
Biomed Pharmacother. 2021 May;137:111382
pubmed: 33761603
ACS Appl Mater Interfaces. 2022 Dec 28;14(51):56548-56559
pubmed: 36521052
Theranostics. 2019 Feb 28;9(6):1634-1650
pubmed: 31037128
Immunity. 2018 Oct 16;49(4):595-613
pubmed: 30332628
Bone Res. 2016 Jul 12;4:16014
pubmed: 27468360
J Allergy Clin Immunol. 2019 May;143(5):1688-1701
pubmed: 30940520
J Immunol. 2008 Sep 15;181(6):3733-9
pubmed: 18768823
J Biomater Appl. 2017 Aug;32(2):139-149
pubmed: 28599578
J Exp Med. 2010 Apr 12;207(4):751-62
pubmed: 20368579
Theranostics. 2021 Oct 11;11(20):9821-9832
pubmed: 34815788
Eur J Cancer. 2017 May;76:118-124
pubmed: 28324746
Langmuir. 2019 Apr 30;35(17):5957-5966
pubmed: 30951314
Bone Res. 2018 Apr 27;6:15
pubmed: 29736302
Front Cell Dev Biol. 2023 Mar 24;11:1123753
pubmed: 37035243
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11488-11493
pubmed: 29073076
Biomaterials. 2017 Oct;143:46-56
pubmed: 28759874
Circ Res. 2018 Mar 16;122(6):877-902
pubmed: 29700084
Clin Dev Immunol. 2013;2013:181849
pubmed: 23762085
Exp Mol Med. 2020 Apr;52(4):691-701
pubmed: 32341419
Nat Commun. 2022 Nov 4;13(1):6648
pubmed: 36333322
Calcif Tissue Int. 2016 Aug;99(2):187-98
pubmed: 27061090
Biomolecules. 2022 Nov 23;12(12):
pubmed: 36551161
Breast Care (Basel). 2014 Oct;9(5):332-6
pubmed: 25759613
J Bone Miner Metab. 2021 Jan;39(1):19-26
pubmed: 33079279
Acta Biomater. 2016 Mar;33:242-51
pubmed: 26796208
Theranostics. 2021 Jan 1;11(1):164-180
pubmed: 33391468
Elife. 2022 Sep 29;11:
pubmed: 36173104
J Clin Invest. 1990 Mar;85(3):632-9
pubmed: 2312718
Bone. 2017 Mar;96:29-37
pubmed: 27742498
J Exp Med. 2005 Aug 1;202(3):345-51
pubmed: 16061724
J Biomed Sci. 2015 Oct 29;22:101
pubmed: 26511009
Gene. 2022 Jan 30;809:146040
pubmed: 34710525
ACS Nano. 2016 Aug 23;10(8):7738-48
pubmed: 27454827
J Bone Miner Res. 2019 Oct;34(10):1789-1797
pubmed: 31067339

Auteurs

Zhaoyang Yin (Z)

Department of Orthopedics, The Affiliated Lianyungang Hospital of Xuzhou Medical University (The First People's Hospital of Lianyungang), Lianyungang, China.

Ge Gong (G)

Department of Geriatrics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Xinhui Liu (X)

Department of Orthopedics, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, China.

Jian Yin (J)

Department of Orthopedics, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH